Male, C, Lensing, AWA, Palumbo, JS, Kumar, R, Nurmeev, I, Hege, K, Bonnet, D, Connor, P, Hooimeijer, HL, Torres, M, Chan, AKC, Kenet, G, Holzhauer, S, Santamaria, A, Amedro, P, Chalmers, E, Simioni, P, Bhat, RV, Yee, DL, Lvova, O, Beyer-Westendorf, J, Biss, TT, Martinelli, I, Saracco, P, Peters, M, Kallay, K, Gauger, CA, Massicotte, MP, Young, G, Pap, AF, Majumder, M, Smith, WT, Heubach, JF, Berkowitz, SD, Thelen, K, Kubitza, D, Crowther, M
, Prins, MH, Monagle, P & EINSTEIN-Jr Phase 3 Investigators 2020, '
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial',
The Lancet Haematology , vol. 7, no. 1, pp. E18-E27.
https://doi.org/10.1016/S2352-3026(19)30219-4